CRISPR Therapeutics AG (CRSP) FCF Margin (2016 - 2026)
CRISPR Therapeutics AG (CRSP) recorded FCF Margin of -711.17% in Q3 2026, up 8817.29 percentage points from -9528.46% a year earlier and up 115.33 percentage points from the prior quarter.
CRISPR Therapeutics AG (CRSP) FCF Margin (2016 - 2026) Analysis & Trends
On a TTM basis, CRISPR Therapeutics AG's FCF Margin came in at -1496.56% as of Sep 30, 2026, down 705.83 percentage points year-over-year; for FY2025, it was -9855.50%, down 9467.78 percentage points from FY2024.
- Annual FCF Margin has a five-year change of +25850.20 percentage points (FY2020 to FY2025).
- Across earlier years, FCF Margin came in at -387.72% in FY2024 (-315.03 pp), -72.69% in FY2023 (+44412.20 pp), -44484.89% in FY2022 (-44534.87 pp) and 49.98% in FY2021 (+35755.68 pp).
- The Q3 2026 figure is the highest quarterly FCF Margin since Q4 2024.
- On a year-over-year basis, FCF Margin rose in four of the last eight quarters, with an average year-over-year change of -622.20 percentage points.
- Peak year-over-year performance for FCF Margin in the last five years was a gain of 1991935.22 percentage points in Q4 2023, against a drop of 1991245.13 percentage points in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at -826.50% (Q2 2026), -7503.50% (Q1 2026) and -10771.99% (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 38.60% |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 28.96% |
| 10 | CRISPR Therapeutics AG | 4.65 Bn | -4.41 Bn | - | -711.17% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -711.17% |
| Jun 30, 2026 | -826.50% |
| Mar 31, 2026 | -7,503.50% |
| Dec 31, 2025 | -10,771.99% |
| Sep 30, 2025 | -9,528.46% |
| Jun 30, 2025 | -12,779.93% |
| Mar 31, 2025 | -6,260.46% |
| Dec 31, 2024 | -140.89% |
| Sep 30, 2024 | -17,796.01% |
| Jun 30, 2024 | -18,624.56% |
| Mar 31, 2024 | 21,633.13% |
| Dec 31, 2023 | -48.12% |
| Jun 30, 2023 | -195.43% |
| Mar 31, 2023 | 5.74% |
| Dec 31, 2022 | -1,991,983.33% |
| Sep 30, 2022 | -118,335.11% |
| Jun 30, 2022 | -95,940.51% |
| Mar 31, 2022 | -16,020.11% |
| Dec 31, 2021 | -738.20% |
| Sep 30, 2021 | -14,366.26% |
CRISPR Therapeutics AG FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=CRSP&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "CRSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=CRSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();